Related Experiment Video

Updated: Jul 10, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis

K Prasad1, A Kumar, P K Gupta

  • 1All India Institute of Medical Sciences, Neurosciences Center, Room No. 704, AIIMS, New Delhi, India, 11002. drkameshwarprasad@yahoo.co.in

The Cochrane Database of Systematic Reviews
|October 19, 2007
PubMed
Abstract

Insights

Third generation cephalosporins show no significant difference in effectiveness or safety compared to conventional antibiotics for acute bacterial meningitis (ABM). This finding is crucial for treatment decisions, especially in low-resource settings.

Area of Science:

  • Infectious Diseases
  • Clinical Pharmacology
  • Evidence-Based Medicine

Background:

  • Immediate antibiotic therapy is vital for suspected acute bacterial meningitis (ABM) before definitive culture results.
  • Guidelines recommend third-generation cephalosporins, but availability is limited in low-income countries.
  • Conventional treatments include penicillin or ampicillin-chloramphenicol.

Purpose of the Study:

  • To compare the effectiveness and safety of third-generation cephalosporins versus conventional antibiotics for community-acquired ABM.
  • To evaluate outcomes such as mortality, deafness, and treatment failure.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs).
  • Searched multiple databases (CENTRAL, MEDLINE, EMBASE) and contacted experts.
  • Included 19 trials involving 1496 patients, assessing methodological quality and extracting data.

Main Results:

  • No statistically significant differences in mortality, deafness, or treatment failure between treatment groups.
  • Third-generation cephalosporins showed a trend towards decreased CSF positivity and increased diarrhea.
  • Most studies were from the 1980s, with a few more recent reports.

Conclusions:

  • No clinically significant difference between third-generation cephalosporins and conventional antibiotics for ABM.
  • Conventional options like ampicillin-chloramphenicol or chloramphenicol alone may be suitable where third-generation cephalosporins are unavailable or unaffordable.
  • Monitoring antimicrobial resistance patterns is essential globally.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...